news

VAXCHORA® is indicated for active immunisation against disease caused by Vibrio cholerae serogroup O1 in adults and children aged 2 years...

As of February 17 2023, Biocelect Pty Ltd is proud to have added IMOJEV (Japanese encephalitis vaccine, live attenuated) to our portfolio...

Biocelect is proud to partner with NSW Health and NOVAVAX INC on clinical trials and making new vaccines available for all Australians

A great profile on our company Founders, Owners and Managing Directors; Karl Herz and Jennifer Herz, who met in 1991. Discussing their...

Biocelect is proud to support Novavax as Sponsor for their COVID-19 vaccine candidate NVX-CoV2373 and assist with roll-out in Australia...

Biocelect is excited to announce its partnership with BioCryst Pharmaceuticals Inc. As a result Biocelect is now the exclusive...

Biocelect announces it's partnership with Korean company SD Biosensor for the TGA approved Standard Q COVID-19 Antigen Test. The test is...

60 Degrees Pharmaceuticals Announces Positive Results of Cell Culture Testing of ARAKODA (tafenoquine) for COVID-19 Find full press...

Biocelect is proud to announce its partnership with Emergent Travel Health (Emergent Biosolutions). As a result Biocelect is now the...

Biocelect attends the Perth Healthed GP Education Day in November 2019. Final leg of the Healthed GP Education National tour completed....

The Biocelect team was pleased to attend and exhibit at the Australian Military Medical Association (AMMA) 2019 Conference "after the WAR...

Two more successful trips for the Biocelect team at the Healthed General Practice Day Conferences taking place across the country this...

Biocelect attends the Adelaide Healthed GP Education Day Saturday 14th September 2019 at the Adelaide Convention Centre. Great day for...

Members from the Biocelect team attend the 4th Annual Southern Cross Travel Medicine Conference(SCTMC 2019) in Sydney (hosted by...

Biocelect attends the Sydney Healthed GP Education Day Saturday 24th August 2019 at Darling Harbour. An interesting, informative and busy...

60 Degrees Pharmaceuticals (60P) and its Australian distribution partner Biocelect Pty Ltd, began commercialising the new malaria...

Biocelect welcomes Australia's Therapeutic Goods Administration (TGA) approval of KODATEF (tafenoquine); the first malaria prevention...

US FDA Advisory Committee votes in favour of 60 Degrees Pharmaceuticals (60P) ARAKODA (tafenoquine) for the prevention of malaria

US FDA approves Krintafel (tafenoquine) for the radical cure of P. vivax malaria